Apyx Medical Corporation (APYX)

Apyx Medical Corporation (APYX) scores 24 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $3.16, representing a 21% premium to fair value. Quantitative score: 42/100. Qualitative score: 20/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full APYX analysis on boothcheck